ACLX

Arcellx
ACLX

Latest price

Financial Snapshot

gainify

Market Data

Market Cap
$3.50B
EV
$2.92B
Shares Outstanding
59.99M
Beta
0.33

Wall Street View

Analyst Rating
BUY
Analyst Target Price
$115.40
P/E 2025E
-
P/Revenue 2025E
39.20x

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About Arcellx, Inc.

gainify
ACLX

Arcellx, Inc.

ACLX

Arcellx, Inc., together with its subsidiary, engages in the development of various immunotherapies for patients with cancer and other incurable diseases in the United States. The company’s lead ddCAR product candidate is anitocabtagene autoleucel, which is in phase 2 ...

Sector

Healthcare

Industry

Biotechnology

CEO

Elghandour, Rami

Employees

163

IPO Date

2022-02-04

Headquarters

800 Bridge Parkway, Redwood City, California, 94065, United States

gainify
mailcontactcontact
powered-by-sp

NEWSLETTER

COMPANY

© Copyright 2025, All Rights Reserved